Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03910075
Other study ID # 1U01NS106655-01A1
Secondary ID
Status Recruiting
Phase Phase 3
First received
Last updated
Start date October 10, 2019
Est. completion date May 1, 2026

Study information

Verified date May 2024
Source Virginia Polytechnic Institute and State University
Contact Laura Bateman, B.S.
Phone 540-526-2033
Email laurapb2@vt.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a Phase III clinical trial to compare the efficacy of two dosages of a new infant rehabilitation protocol - I-ACQUIRE - to usual and customary forms of infant rehabilitation in infants who experienced Perinatal Arterial Stroke (PAS).


Description:

The proposed study is a Phase III trial powered to determine efficacy of two different doses of I-ACQUIRE for children 8 to 36 months old with PAS and hemiparesis. The design is a prospective Randomized Controlled Trial (RCT) in which 240 children will be randomly assigned to one of 3 treatment groups (N=80 per group): 1) Moderate Dose I-ACQUIRE (3 hrs/day, 5 day/wk X 4 wks), 2) High Dose I-ACQUIRE (6hrs/day, 5 days/wk X 4 wks), or 3) Usual and Customary Treatment (U&CT). I-ACQUIRE will be delivered by protocol-trained therapists and monitored weekly for dosage and treatment fidelity; U&CT will be provided by community therapists with dosage and approaches documented weekly. All primary and secondary efficacy outcomes rely on blinded assessments at baseline, end of treatment, and 6 mos post-treatment. Exploratory outcomes and supplemental clinical measures may provide valuable additional data about development and health in this sample of children with PAS.


Recruitment information / eligibility

Status Recruiting
Enrollment 240
Est. completion date May 1, 2026
Est. primary completion date October 1, 2025
Accepts healthy volunteers No
Gender All
Age group 8 Months to 36 Months
Eligibility Inclusion Criteria: - child will be 8 - 36 months old when study treatment will be delivered - child has a diagnosis of Perinatal Arterial Stroke (PAS) - parent permission to provide the child's clinical MRI to the study - child has hemiparesis - parent(s) willing to participate in the home therapy component - one parent English language proficient and will take the lead in interacting with study staff and completing self-administered forms and interviews in English Exclusion Criteria: - child has medical or sensory condition(s) that prevent(s) full therapy participation (e.g., frequent uncontrolled seizures, fragile health) - child previously received Constraint-Induced Movement Therapy (CIMT) or modified CIMT with a dose of at least 2 hrs/day for =10 days - child received botulinum toxin in past 3 months - child is a ward of the state or other agency

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
I-ACQUIRE - High Dosage
Children in this group will receive 6 hours of I-ACQUIRE therapy daily, 5 days a week for 4 consecutive weeks. Treatment is delivered in the home or homelike setting by a study trained I-ACQUIRE pediatric therapist.
I-ACQUIRE - Moderate Dosage
Children in this group will receive 3 hours of I-ACQUIRE therapy daily, 5 days a week for 4 consecutive weeks. Treatment is delivered in the home or homelike setting by a study trained I-ACQUIRE pediatric therapist.
Usual & Customary Treatment (U&CT)
Children in this group will receive the same U&CT that they had been receiving prior to the baseline assessment. The type and dosage of treatment(s) will be documented weekly.

Locations

Country Name City State
United States C.S. Mott Children's Hospital Ann Arbor Michigan
United States Kennedy Krieger Institute - Fairmount Rehabilitation Baltimore Maryland
United States Boston Children's Hospital Boston Massachusetts
United States The Medical University of South Carolina (MUSC) Charleston South Carolina
United States Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois
United States Cincinnati Children's Hospital Medical Center Cincinnati Ohio
United States Martha Morehouse Medical Plaza Columbus Ohio
United States Scottish Rite for Children - Dallas Dallas Texas
United States Memorial Hermann Texas Medical Center Houston Texas
United States USCD Health La Jolla La Jolla California
United States University of Wisconsin School of Medicine and Public Health Madison Wisconsin
United States Yale New Haven Children's Hospital New Haven Connecticut
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania
United States Fralin Biomedical Research Institute at Virginia Tech Roanoke Virginia
United States Washington University School of Medicine, St. Louis Children's Hospital Saint Louis Missouri

Sponsors (6)

Lead Sponsor Collaborator
Virginia Polytechnic Institute and State University Medical University of South Carolina, Nationwide Children's Hospital, Ohio State University, Stanford University, University of Cincinnati

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Emerging Behaviors Scale (EBS) Score The primary efficacy is measured by the Emerging Behaviors Scale (EBS) that counts the number of upper extremity skills on the hemiparetic side that the child displays (from 0 to 30). The source for observation comes from a battery of standardized age-appropriate neuromotor assessment tools (Gross Motor Function Measure-66, The Bayley III Fine and Gross Motor scales, unilateral skills during the Mini AHA) and independent observational coding of the videotaped assessment session with supplemental parent ratings on the Infant Motor Activity Log and daily skills on the MacArthur-Bates Communicative Development Inventory. A favorable outcome is defined as a gain of =7 new EBS skills above the child's baseline (pre-treatment) score. The EBS requires evidence of each skill from at least two independent sources. Both immediately after treatment (within 7 days) and 6 months (plus or minus 2 months) post-treatment
Secondary Changes in Bilateral Use of the Hemiparetic Upper Extermity based on the Mini-Assisting Hand Assessment (Mini-AHA) play assessment The secondary efficacy outcome is measured by increases in the use of the hemiparetic upper extremity while engaged in bilateral activities during the interactive play session of the Mini-AHA. Each item is scored on a 4-pt scale where the points are behaviorally anchored and adjusted for the child's age range. Raw scores are converted into a summary Logit score (0 to 100) based on Item Response Theory analyses, indicating the relative difficulty and sequence in which certain levels of performance appear. For this metric, higher scores are considered better. Both immediately after treatment (within 7 days) and 6 months (plus or minus 2 months) post-treatment
See also
  Status Clinical Trial Phase
Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
Completed NCT03780296 - Implementing Technology Enhanced Real Time Action Observation Therapy in Persons With Chronic Stroke N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Recruiting NCT05163210 - Effectiveness of AOT Based on Virtual Reality in Stroke Rehabilitation. N/A
Terminated NCT04113525 - Transcutaneous Spinal and Peripheral Stimulation and Wrist Robotic Therapy for Patients With Spastic Stroke N/A
Completed NCT01948739 - Brain Machine Interface Control of an Robotic Exoskeleton in Training Upper Extremity Functions in Stroke N/A
Not yet recruiting NCT03237520 - Comparing Virtual Reality Therapy With Modified-CIMT Versus Modified-CIMT Alone in Hemiparetic Children N/A
Completed NCT03080454 - The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke Phase 1/Phase 2
Suspended NCT01519843 - Post Stroke Motor Learning N/A
Completed NCT01651533 - Mental Practice in Chronic, Stroke Induced Hemiparesis N/A
Completed NCT01106755 - Effects of Ground Level Gait Training With Body Weight Support (BWS) and Functional Electrical Stimulation (FES) N/A
Active, not recruiting NCT00170716 - Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis Phase 3
Completed NCT04286997 - VARA (Virtual and Augmented Reality Applications in Rehabilitation): Motor Rehabilitation Protocol With GRAIL for Patients Affected by Hemiparesis N/A
Completed NCT05856669 - The Effects of Mirror-Based Virtual Reality Systems and Recalibration Software on Upper Extremity Function in Individuals Experiencing Hemiparesis Post-Stroke N/A
Recruiting NCT05801874 - Gait and Posture Analysis in Hemiparetic Patients Through Optoelectronic Systems, "Smart" Tools and Clinical Evaluation
Recruiting NCT05590988 - Sensorimotor Arm Rehabilitation After Stroke N/A
Completed NCT04536987 - Robot Therapy for Rehabilitation of Hand Movement After Stroke Phase 2
Recruiting NCT04694833 - Telerehabilitation Through Serious Games in Virtual Reality in a Stroke Population (AutoRReVi) N/A
Completed NCT03965403 - Upper Extremity Rehabilitation With the BURT Robotic Arm N/A
Not yet recruiting NCT03638570 - Altered Connections in the Spinal Cord to Reduce Hand Impairment After Stroke N/A